1 completed, 1 terminated. 2 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 2 | Completed 1, Terminated 1 |
Follow Zymar: new trials by email Literature Review of Zymar trials Research Report on Zymar
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%. Pazufloxacin, Zymar - Conjunctivitis, Bacterial | Phase 3 | Terminated | Laboratorios Sophia S.A de C.V. | 46 | 2018-10-01 | 2021-08-24 |
| Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/Inflammation 0.3% gatifloxacin and 1.0% prednisolone acetate association, isolated 0.3% gatifloxacin and 1.0% prednisolone acetate - Ocular Infection and Inflammation | Phase 3 | Completed | Federal University of São Paulo | 101 | 2009-01-01 | 2018-03-21 |
Conjunctivitis, Bacterial (1) · Eye Infections (1) · Inflammation (1)
Federal University of São Paulo (1) · Laboratorios Sophia S.A de C.V. (1)
Brazil (1) · Mexico (1)